Our Team

Our founder-led, interdisciplinary team has been involved in the approval of 25 drugs and the investigation of more than 100.

Leadership

Amit Etkin, MD, PhD

Founder and Chief Executive Officer

Dan Segal

Co-Founder and Chief Operating Officer

Adam Savitz, MD, PhD

Chief Medical Officer

Wei Wu, PhD

Co-Founder and Chief Data Science Officer

Nick Smith

Chief Business Officer

Lesley Parker

Vice President, Clinical Operations

Bruce Morimoto, PhD

Vice President, Drug Development

Fadi Abdel, PhD

Vice President, Clinical Innovation

Scientific Advisors

Tom Insel, MD

Former Director, NIMH

Madhukar Trivedi, MD

Professor, UTSW

Alan Schatzberg, MD

Professor, Stanford

Fei-Fei Li, PhD

Professor, Stanford

Board of Directors

Amit Etkin, MD, PhD

Founder and Chief Executive Officer

Dan Segal

Co-Founder and Chief Operating Officer

Gwill York, MBA

Founding Managing Director, Lighthouse Capital Partners

Aaron Weaver

Principal, Apeiron Investment Group

Receive updates from Alto
Thanks for signing up!
Oops! Something went wrong while submitting the form.